Skip to content

Opening book details…

About this Medicine article

Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials? by Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polakova; Jana Moravcova; Tomas Jurcek; Dana Dvorakova; Zdenek Racil; Zdenek Pospisil; Alexandra Oltova; Kyra Michalova; Jana Brezinova; Filip Razga; Michael Doubek; Petr Cetkovsky; Marek Trneny; Jiri Mayer is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polakova; Jana Moravcova; Tomas Jurcek; Dana Dvorakova; Zdenek Racil; Zdenek Pospisil; Alexandra Oltova; Kyra Michalova; Jana Brezinova; Filip Razga; Michael Doubek; Petr Cetkovsky; Marek Trneny; Jiri Mayer
Publisher
John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley; Research Square (ISSN 0361-8609)
Published
2011
Language
EN
Field
Medicine (Health Sciences)

More by Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polakova; Jana Moravcova; Tomas Jurcek; Dana Dvorakova; Zdenek Racil; Zdenek Pospisil; Alexandra Oltova; Kyra Michalova; Jana Brezinova; Filip Razga; Michael Doubek; Petr Cetkovsky; Marek Trneny; Jiri Mayer

Browse all works by Daniela Zackova; Hana Klamova; Ladislav Dusek; Jan Muzik; Katerina Machova Polakova; Jana Moravcova; Tomas Jurcek; Dana Dvorakova; Zdenek Racil; Zdenek Pospisil; Alexandra Oltova; Kyra Michalova; Jana Brezinova; Filip Razga; Michael Doubek; Petr Cetkovsky; Marek Trneny; Jiri Mayer